- Home
- CNDT vs CYRX Comparison
CNDT vs CYRX Comparison
Compare CNDT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNDT
- CYRX
- Stock Information
- Founded
- CNDT 2016
- CYRX 1999
- Country
- CNDT United States
- CYRX United States
- Employees
- CNDT N/A
- CYRX N/A
- Industry
- CNDT Business Services
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- CNDT Consumer Discretionary
- CYRX Health Care
- Exchange
- CNDT Nasdaq
- CYRX Nasdaq
- Market Cap
- CNDT 393.4M
- CYRX 438.7M
- IPO Year
- CNDT N/A
- CYRX N/A
- Fundamental
- Price
- CNDT $2.78
- CYRX $8.86
- Analyst Decision
- CNDT
- CYRX Strong Buy
- Analyst Count
- CNDT 0
- CYRX 10
- Target Price
- CNDT N/A
- CYRX $11.70
- AVG Volume (30 Days)
- CNDT 1.1M
- CYRX 1.1M
- Earning Date
- CNDT 08-06-2025
- CYRX 08-05-2025
- Dividend Yield
- CNDT N/A
- CYRX N/A
- EPS Growth
- CNDT N/A
- CYRX N/A
- EPS
- CNDT 0.06
- CYRX 1.35
- Revenue
- CNDT $3,112,000,000.00
- CYRX $237,879,000.00
- Revenue This Year
- CNDT N/A
- CYRX N/A
- Revenue Next Year
- CNDT $3.08
- CYRX $9.08
- P/E Ratio
- CNDT $45.22
- CYRX $6.59
- Revenue Growth
- CNDT N/A
- CYRX 24.93
- 52 Week Low
- CNDT $1.90
- CYRX $4.58
- 52 Week High
- CNDT $4.90
- CYRX $9.48
- Technical
- Relative Strength Index (RSI)
- CNDT 57.62
- CYRX 58.38
- Support Level
- CNDT $2.74
- CYRX $8.57
- Resistance Level
- CNDT $2.94
- CYRX $8.99
- Average True Range (ATR)
- CNDT 0.12
- CYRX 0.47
- MACD
- CNDT 0.03
- CYRX -0.02
- Stochastic Oscillator
- CNDT 69.52
- CYRX 71.34
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.